Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
Clinical trial NCT00422487 · COMPLETED
Trial details
- NCT number
- NCT00422487
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.